|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu
K, Zeng Q, Zeng L, Pan Y, Chen ZS and He Y: Signaling pathways and
therapeutic interventions in gastric cancer. Signal Transduct
Target Ther. 7(358)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Yeoh KG and Tan P: Mapping the genomic
diaspora of gastric cancer. Nat Rev Cancer. 22:71–84.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sexton RE, Al Hallak MN, Diab M and Azmi
AS: Gastric cancer: A comprehensive review of current and future
treatment strategies. Cancer Metastasis Rev. 39:1179–1203.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Cai H, Li M, Deng R, Wang M and Shi Y:
Advances in molecular biomarkers research and clinical application
progress for gastric cancer immunotherapy. Biomark Res.
10(67)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zang YS, Dai C, Xu X, Cai X, Wang G, Wei
J, Wu A, Sun W, Jiao S and Xu Q: Comprehensive analysis of
potential immunotherapy genomic biomarkers in 1000 Chinese patients
with cancer. Cancer Med. 8:4699–4708. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thompson CB, Wang CY, Ho IC, Bohjanen PR,
Petryniak B, June CH, Miesfeldt S, Zhang L, Nabel GJ, Karpinski B,
et al: cis-acting sequences required for inducible interleukin-2
enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell
Biol. 12:1043–1053. 1992.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tsokos GC, Nambiar MP and Juang YT:
Activation of the Ets transcription factor Elf-1 requires
phosphorylation and glycosylation: Defective expression of
activated Elf-1 is involved in the decreased TCR zeta chain gene
expression in patients with systemic lupus erythematosus. Ann NY
Acad Sci. 987:240–245. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Andrews PGP, Kennedy MW, Popadiuk CM and
Kao KR: Oncogenic activation of the human Pygopus2 promoter by
E74-like factor-1. Mol Cancer Res. 6:259–266. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hu M, Li H, Xie H, Fan M, Wang J, Zhang N,
Ma J and Che S: ELF1 transcription factor enhances the progression
of glioma via ATF5 promoter. ACS Chem Neurosci. 12:1252–1261.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Yang B, Shen F, Zhu Y, Lu W and Cai H:
E74-like ETS transcription factor 1 promotes the progression of
pancreatic cancer by regulating doublecortin-like kinase 1/Janus
kinase/signal transducer and activator of transcription pathway. Am
J Cancer Res. 14:616–629. 2024.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang J, Chen L, Wei W and Mao F: Long
non-coding RNA signature for predicting gastric cancer survival
based on genomic instability. Aging (Albany NY). 15:15114–15133.
2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xu TP, Wang YF, Xiong WL, Ma P, Wang WY,
Chen WM, Huang MD, Xia R, Wang R, Zhang EB, et al: E2F1 induces
TINCR transcriptional activity and accelerates gastric cancer
progression via activation of TINCR/STAU1/CDKN2B signaling axis.
Cell Death Dis. 8(e2837)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
He DX, Zhang GY, Gu XT, Mao AQ, Lu CX, Jin
J, Liu DQ and Ma X: Genome-wide profiling of long non-coding RNA
expression patterns in anthracycline-resistant breast cancer cells.
Int J Oncol. 49:1695–1703. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zeltz C, Primac I, Erusappan P, Alam J,
Noel A and Gullberg D: Cancer-associated fibroblasts in
desmoplastic tumors: Emerging role of integrins. Semin Cancer Biol.
62:166–181. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Harrison JD and Fielding JW: Prognostic
factors for gastric cancer influencing clinical practice. World J
Surg. 19:496–500. 1995.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Grzesiak M, Kaminska K, Knapczyk-Stwora K
and Hrabia A: The expression and localization of selected matrix
metalloproteinases (MMP-2, -7 and -9) and their tissue inhibitors
(TIMP-2 and -3) in follicular cysts of sows. Theriogenology.
185:109–120. 2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang Y, Chuang CY, Hawkins CL and Davies
MJ: Activation and inhibition of human matrix metalloproteinase-9
(MMP9) by HOCl, myeloperoxidase and chloramines. Antioxidants
(Basel). 11(1616)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Farina AR and Mackay AR: Gelatinase
B/MMP-9 in tumour pathogenesis and progression. Cancers (Basel).
6:240–296. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Buttacavoli M, Di Cara G, Roz E,
Pucci-Minafra I, Feo S and Cancemi P: Integrated multi-omics
investigations of metalloproteinases in colon cancer: Focus on MMP2
and MMP9. Int J Mol Sci. 22(12389)2021.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Teng Z, Wang S, Yuan H, Wang H, Li J,
Chang X, Zhang Y, Han Z and Wang Y: MMP-9 gene polymorphisms on
cancer risk: An updated systematic review and meta-analysis.
Nucleosides Nucleotides Nucleic Acids. 3:1–24. 2024.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fu CK, Chang WS, Tsai CW, Wang YC, Yang
MD, Hsu HS, Chao CY, Yu CC, Chen JC, Pei JS and Bau DT: The
association of MMP9 promoter Rs3918242 genotype with gastric
cancer. Anticancer Res. 41:3309–3315. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Costache S, Sajin M, Wedden S and D'Arrigo
C: A consolidated working classification of gastric cancer for
histopathologists (review). Biomed Rep. 19(58)2023.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu JY, Peng CW, Yang XJ, Huang CQ and Li
Y: The prognosis role of AJCC/UICC 8th edition staging system in
gastric cancer, a retrospective analysis. Am J Transl Res.
10:292–303. 2018.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Liao Q and Xiong J: YTHDF1 regulates
immune cell infiltration in gastric cancer via interaction with
p53. Exp Ther Med. 27(255)2024.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cancer Genome Atlas Research Network.
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature. 513:202–209. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q,
Li B and Liu XS: TIMER2.0 for analysis of tumor-infiltrating immune
cells. Nucleic Acids Res. 48 (W1):W509–W514. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Newman AM, Liu CL, Green MR, Gentles AJ,
Feng W, Xu Y, Hoang CD, Diehn M and Alizadeh AA: Robust enumeration
of cell subsets from tissue expression profiles. Nat Methods.
12:453–457. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Usui G, Matsusaka K, Mano Y, Urabe M,
Funata S, Fukayama M, Ushiku T and Kaneda A: DNA methylation and
genetic aberrations in gastric cancer. Digestion. 102:25–32.
2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Quan Q, Guo L, Huang L, Liu Z, Guo T, Shen
Y, Ding S, Liu C and Cao L: Expression and clinical significance of
PD-L1 and infiltrated immune cells in the gastric adenocarcinoma
microenvironment. Medicine (Baltimore). 102(e36323)2023.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Liu D, Heij LR, Czigany Z, Dahl E, Lang
SA, Ulmer TF, Luedde T, Neumann UP and Bednarsch J: The role of
tumor-infiltrating lymphocytes in cholangiocarcinoma. J Exp Clin
Cancer Res. 41(127)2022.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Alhalabi MM, Alsayd SA and Albattah ME:
Advanced diffuse gastric adenocarcinoma in young Syrian woman. A
case report. Ann Med Surg (Lond). 78(103728)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tuei VC, Maiyoh GK and Ndombera FT: The
role of infections in the causation of cancer in Kenya. Cancer
Causes Control. 33:1391–1400. 2022.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Chang ZW, Dong L, Qin YR, Song M, Guo HY
and Zhu QL: Correlations between gastric cancer family history and
ROBO2 and RASSF2A gene methylations. J Cancer Res Ther. 12:597–600.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tan AC, Chan DL, Faisal W and Pavlakis N:
New drug developments in metastatic gastric cancer. Therap Adv
Gastroenterol. 11(1756284818808072)2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Li Z, Zhao Z, Wang C, Wang D, Mao H, Liu
F, Yang Y, Tao F and Lu Z: Association between DCE-MRI perfusion
histogram parameters and EGFR and VEGF expressions in different
lauren classifications of advanced gastric cancer. Pathol Oncol
Res. 27(1610001)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
He Y and Wang X: Identification of
molecular features correlating with tumor immunity in gastric
cancer by multi-omics data analysis. Ann Transl Med.
8(1050)2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Hsing M, Wang Y, Rennie PS, Cox ME and
Cherkasov A: ETS transcription factors as emerging drug targets in
cancer. Med Res Rev. 40:413–430. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Oettgen P, Akbarali Y, Boltax J, Best J,
Kunsch C and Libermann TA: Characterization of NERF, a novel
transcription factor related to the Ets factor ELF-1. Mol Cell
Biol. 16:5091–5106. 1996.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li T, Jia Z, Liu J, Xu X, Wang H, Li D and
Qiu Z: Transcription activation of SPINK4 by ELF-1 augments
progression of colon cancer by regulating biological behaviors.
Tissue Cell. 84(102190)2023.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Takai N, Miyazaki T, Nishida M, Shang S,
Nasu K and Miyakawa I: Clinical relevance of Elf-1 overexpression
in endometrial carcinoma. Gynecol Oncol. 89:408–413.
2003.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Takai N, Miyazaki T, Nishida M, Nasu K and
Miyakawa I: The significance of Elf-1 expression in epithelial
ovarian carcinoma. Int J Mol Med. 12:349–354. 2003.PubMed/NCBI
|
|
46
|
Cheng M, Zeng Y, Zhang T, Xu M, Li Z and
Wu Y: Transcription factor ELF1 activates MEIS1 transcription and
then regulates the GFI1/FBW7 axis to promote the development of
glioma. Mol Ther Nucleic Acids. 23:418–430. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Qiao C, Qiao T, Yang S, Liu L and Zheng M:
SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional
regulation of CTNNB1 to activate Wnt/β-catenin pathway in oral
squamous cell carcinoma. Cancer Gene Ther. 29:122–132.
2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Budka JA, Ferris MW, Capone MJ and
Hollenhorst PC: Common ELF1 deletion in prostate cancer bolsters
oncogenic ETS function, inhibits senescence and promotes docetaxel
resistance. Genes Cancer. 9:198–214. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Paczkowska J, Soloch N, Bodnar M, Kiwerska
K, Janiszewska J, Vogt J, Domanowska E, Martin-Subero JI, Ammerpohl
O, Klapper W, et al: Expression of ELF1, a lymphoid ETS
domain-containing transcription factor, is recurrently lost in
classical Hodgkin lymphoma. Br J Haematol. 185:79–88.
2019.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Karamanos NK, Theocharis AD, Piperigkou Z,
Manou D, Passi A, Skandalis SS, Vynios DH, Orian-Rousseau V,
Ricard-Blum S, Schmelzer CEH, et al: A guide to the composition and
functions of the extracellular matrix. FEBS J. 288:6850–6912.
2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Peltonen R, Hagström J, Tervahartiala T,
Sorsa T, Haglund C and Isoniemi H: High expression of MMP-9 in
primary tumors and high preoperative MPO in serum predict improved
prognosis in colorectal cancer with operable liver metastases.
Oncology. 99:144–160. 2021.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wang T, Zhang Y, Bai J, Xue Y and Peng Q:
MMP1 and MMP9 are potential prognostic biomarkers and targets for
uveal melanoma. BMC Cancer. 21(1068)2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Xu T, Gao S, Liu J, Huang Y, Chen K and
Zhang X: MMP9 and IGFBP1 regulate tumor immune and drive tumor
progression in clear cell renal cell carcinoma. J Cancer.
12:2243–2257. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Quintero-Fabián S, Arreola R,
Becerril-Villanueva E, Torres Romero JC, Arana-Argáez V,
Lara-Riegos J, Ramírez Camacho MA and Alvarez-Sánchez ME: Role of
matrix metalloproteinases in angiogenesis and cancer. Front Oncol.
9(1370)2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Liu C, Shen Y and Tan Q: Diagnostic and
prognostic values of MMP-9 expression in ovarian cancer: A study
based on bioinformatics analysis and meta-analysis. Int J Biol
Markers. 38:15–24. 2023.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Jiang H and Li H: Prognostic values of
tumoral MMP2 and MMP9 overexpression in breast cancer: A systematic
review and meta-analysis. BMC Cancer. 21(149)2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Shao W, Wang W, Xiong XG, Cao C, Yan TD,
Chen G, Chen H, Yin W, Liu J, Gu Y, et al: Prognostic impact of
MMP-2 and MMP-9 expression in pathologic stage IA non-small cell
lung cancer. J Surg Oncol. 104:841–846. 2011.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lin Z, Liu Y, Sun Y and He X: Expression
of Ets-1, Ang-2 and maspin in ovarian cancer and their role in
tumor angiogenesis. J Exp Clin Cancer Res. 30(31)2011.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhang L, Li X, Feng X, Berkman T, Ma R, Du
S, Wu S, Huang C, Amponsah A, Bekker A and Tao YX: E74-like factor
1 contributes to nerve trauma-induced nociceptive hypersensitivity
through transcriptionally activating matrix metalloprotein-9 in
dorsal root ganglion neurons. Pain. 164:119–131. 2023.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Wang L: ELF1-activated FOXD3-AS1 promotes
the migration, invasion and EMT of osteosarcoma cells via sponging
miR-296-5p to upregulate ZCCHC3. J Bone Oncol.
26(100335)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Liu Y, Ma R, Juan D, Yuan Z, Sun J, Wang
M, Li Y, Bao Y and Jin H: Adipose-derived mesenchymal stem
cell-loaded β-chitin nanofiber hydrogel activates the AldoA/HIF-1α
pathway to promote diabetic wound healing. Am J Stem Cells.
12:1–11. 2023.PubMed/NCBI
|
|
62
|
Wang Y, Hu C, Kwok T, Bain CA, Xue X,
Gasser RB, Webb GI, Boussioutas A, Shen X, Daly RJ and Song J:
DEMoS: a deep learning-based ensemble approach for predicting the
molecular subtypes of gastric adenocarcinomas from
histopathological images. Bioinformatics. 38:4206–4213.
2022.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Bonsang B, Maksimovic L, Maille P, Martin
N, Laurendeau I, Pasmant E, Bièche I, Deschamps J, Wolkenstein P
and Ortonne N: VEGF and VEGFR family members are expressed by
neoplastic cells of NF1-associated tumors and may play an oncogenic
role in malignant peripheral nerve sheath tumor growth through an
autocrine loop. Ann Diagn Pathol. 60(151997)2022.PubMed/NCBI View Article : Google Scholar
|
|
64
|
De Re V, Alessandrini L, Brisotto G,
Caggiari L, De Zorzi M, Casarotto M, Miolo G, Puglisi F, Garattini
SK, Lonardi S, et al: HER2-CDH1 interaction via Wnt/B-catenin is
associated with patients' survival in HER2-positive metastatic
gastric adenocarcinoma. Cancers (Basel). 14(1266)2022.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Qin X, Chen Y, Ma S, Shen L and Ju S:
Immune-related gene TM4SF18 could promote the metastasis of gastric
cancer cells and predict the prognosis of gastric cancer patients.
Mol Oncol. 16:4043–4059. 2022.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Liu C, Omilusik K, Toma C, Kurd NS, Chang
JT, Goldrath AW and Wang W: Systems-level identification of key
transcription factors in immune cell specification. PLoS Comput
Biol. 18(e1010116)2022.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Klugman M, Fazzari M, Xue X, Ginsberg M,
Rohan TE, Halmos B, Hanna DB, Shuter J and Hosgood HD III: The
associations of CD4 count, CD4/CD8 ratio, and HIV viral load with
survival from non-small cell lung cancer in persons living with
HIV. AIDS Care. 34:1014–1021. 2022.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Fridman WH, Petitprez F, Meylan M, Chen
TWW, Sun CM, Roumenina LT and Sautès-Fridman C: B cells and cancer:
To B or not to B? J Exp Me. 218(e20200851)2021.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Peña-Romero AC and Orenes-Piñero E: Dual
effect of immune cells within tumour microenvironment: Pro- and
anti-tumour effects and their triggers. Cancers (Basel).
14(1681)2022.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Dou A and Fang J: Heterogeneous myeloid
cells in tumors. Cancers (Basel). 13(3772)2021.PubMed/NCBI View Article : Google Scholar
|
